Recombinant Anopheles gambiae Protein crossbronx homolog (AGAP010478)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is crucial for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If a specific tag type is required, please inform us, and we will prioritize its development.
Synonyms
AGAP010478Protein crossbronx homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-228
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Anopheles gambiae (African malaria mosquito)
Target Names
AGAP010478
Target Protein Sequence
MTLDANDKLL EAVLQEYKIL AEYERLQSED LGGIYVTPSY ENPFLWFGVI FVRSGMYKDG VFRFTISLPN RFPNDSTVPV VAFQSDVFHP MVNPSDGVLN LSDTFPKWQS GDSHIWQMLK FVQFILQNLD DHTIPSEHVV NNEAYQLLME NRAEFLLRVE QCVEDSQRKL YDLPAQPDRF YICFDRFNPD VHGPVLQSMK EDKPTEVTTP PSSGLSWVRK GFYQPLSK
Uniprot No.

Q&A

What is AGAP010478 and what is its significance in Anopheles gambiae research?

AGAP010478, commonly referred to as the crossbronx homolog, is a protein found in the Anopheles gambiae mosquito, a primary vector for malaria transmission in sub-Saharan Africa. This protein has garnered significant research interest due to its potential role in insecticide resistance mechanisms and vector control strategies. Studies examining the molecular functions of AGAP010478 contribute to our understanding of mosquito biology and may inform novel approaches to malaria control .

What expression systems are most effective for producing recombinant AGAP010478?

  • Balance between plasmid copy number and promoter strength

  • Selection of appropriate host strain (BL21 derivatives show higher recombinant protein production with reduced acetate excretion)

  • Growth medium optimization (rich medium with glucose or glycerol as carbon sources)

  • Induction conditions and timing

The metabolic burden associated with transcription and translation of foreign genes can decrease expression efficiency, necessitating careful system optimization .

How should data tables be structured when reporting AGAP010478 research findings?

When reporting research findings related to recombinant AGAP010478, data tables should be structured to clearly communicate experimental results. Follow these guidelines for effective data table creation:

Table Structure Guidelines:

  • Create a clear title describing the purpose of the experiment

  • Place the independent variable (what you purposefully change) in the left column

  • Place the dependent variable (what you measure) with different trials in subsequent columns

  • Include a derived or calculated column (often average) on the far right

  • Ensure proper units are included in each column header

Example Table Format for AGAP010478 Expression Analysis:

Expression SystemAGAP010478 Yield (mg/L)Average Yield (mg/L)
Trial 1Trial 2Trial 3
E. coli BL21(DE3)X.XX.XX.XX.X
E. coli BL21(DE3)pLysSX.XX.XX.XX.X
P. pastorisX.XX.XX.XX.X

This standardized approach ensures data clarity and facilitates comparison across different experimental conditions .

What purification methods are recommended for recombinant AGAP010478?

Purification of recombinant AGAP010478 typically involves a multi-step process designed to achieve high purity while maintaining protein functionality. Based on recombinant protein research, the following methods are recommended:

  • Initial clarification: Centrifugation or filtration to remove cellular debris

  • Capture phase: Affinity chromatography (if protein is tagged, such as with His6 or GST)

  • Intermediate purification: Ion exchange chromatography based on the protein's isoelectric point

  • Polishing step: Size exclusion chromatography to remove aggregates and obtain homogeneous protein

For challenging cases, consider using innovative approaches such as the vesicle-nucleating peptide tag system, which has been shown to significantly increase yields of recombinant proteins that are otherwise difficult to express or purify. This system compartmentalizes proteins within a micro-environment that facilitates the production of challenging, toxic, insoluble, or disulfide-bond containing proteins from bacteria .

How does AGAP010478 contribute to insecticide resistance mechanisms in Anopheles gambiae?

Research into insecticide resistance mechanisms in Anopheles gambiae has identified several proteins that play crucial roles in metabolic resistance. While specific studies on AGAP010478 are emerging, related research has identified cytochrome P450 enzymes, particularly CYP6M2, as capable of metabolizing both organochlorine insecticides (like DDT) and pyrethroids.

Studies examining cross-resistance mechanisms have found that in DDT-resistant populations of A. gambiae s.s. from Ghana, metabolic genes including cytochrome P450s were significantly overexpressed. Of particular note, CYP6M2 was found to metabolize both DDT (in the presence of solubilizing factor sodium cholate) and pyrethroids, demonstrating how a single enzyme can confer resistance to multiple insecticide classes.

When investigating AGAP010478's potential role in resistance mechanisms, researchers should:

  • Examine expression levels in resistant versus susceptible mosquito populations

  • Conduct in vitro metabolism assays with recombinant protein

  • Perform gene knockout or knockdown studies to assess phenotypic changes

  • Analyze structural features that may enable interaction with multiple insecticide classes

What adaptive sampling designs are most effective for field studies involving AGAP010478 expression in wild Anopheles gambiae populations?

When designing field studies to investigate AGAP010478 expression in wild Anopheles gambiae populations, adaptive spatial sampling designs have shown significant advantages. Based on recent research in southwestern Benin, a two-phase adaptive approach is recommended:

Phase I: Initial Sampling

  • Delineate ecological zones relevant to mosquito habitats

  • Employ a proportional lattice with close pairs sampling design

  • Maximize spatial coverage and representativeness of ecological zones

  • Account for spatial dependence in mosquito counts

Phase II: Adaptive Sampling

  • Focus on high-risk areas with greatest uncertainty identified from Phase I

  • Employ a Poisson generalized linear mixed model with spatiotemporal random fields

  • Consider batch size for new locations to add to the first-phase sampling

  • Develop a utility function to rank unobserved locations

How should researchers address contradictory results in AGAP010478 expression studies across different mosquito populations?

When confronted with contradictory results in AGAP010478 expression studies across different mosquito populations, researchers should implement a systematic approach to data analysis and interpretation:

  • Metadata Analysis: Thoroughly examine experimental conditions, including:

    • Collection sites and ecological conditions

    • Mosquito species and molecular forms (M vs. S form)

    • Insecticide exposure history

    • Season of collection

  • Statistical Approaches for Heterogeneous Data:

    • Consider meta-analytic techniques that account for study design differences

    • Examine pooled data using prospective meta-analysis

    • Analyze data from similar study designs separately before attempting integration

  • Molecular Form Consideration:

    • Research has shown significant differences between M and S molecular forms of A. gambiae, with the M form showing different mating strategies and higher insemination rates in some studies (15% vs. 6%)

    • Expression patterns may vary between forms and should be analyzed separately

  • Validation Studies:

    • Design validation experiments specifically targeting areas of contradiction

    • Consider cross-laboratory validation to address methodological variations

What are the optimal conditions for functional characterization of recombinant AGAP010478?

Functional characterization of recombinant AGAP010478 requires careful optimization of experimental conditions to ensure reliable results. Based on recombinant protein research, consider the following:

Expression Optimization:

  • Test multiple promoter systems (T7, trc, tac, BAD) with different strengths

  • Compare different origins of replication (pMB1, p15A) for optimal copy number

  • Evaluate expression in multiple E. coli strains, including specialized strains for challenging proteins

Purification Considerations:

  • Determine optimal buffer conditions through stability screening

  • Test multiple affinity tags to identify those with minimal impact on function

  • Consider on-column refolding for proteins prone to aggregation

Functional Assays:

  • Develop activity assays specific to the predicted function

  • Include positive and negative controls in all functional tests

  • Consider protein-protein interaction studies to identify binding partners

  • Validate activity under physiologically relevant conditions

How can combined data from heterogeneous study designs be effectively analyzed when researching AGAP010478 across multiple laboratories?

When analyzing combined data from heterogeneous study designs across multiple laboratories investigating AGAP010478, researchers should consider the following methodological approaches:

  • Separate Analysis: Analyze and report each project separately, maintaining the integrity of individual study designs.

  • Individual-Level Analysis: Combine data from all projects and perform an individual-level analysis when study designs are sufficiently similar.

  • Design-Based Pooling: Pool data only from projects having similar study designs to maintain methodological consistency.

  • Prospective Meta-Analysis: Analyze pooled data using a prospective meta-analytic technique that accounts for between-study heterogeneity.

  • Simulated Group Design: For more complex scenarios, consider analyzing pooled data utilizing a novel simulated group randomized design.

Each approach offers different advantages in terms of:

  • Ability to incorporate data from all projects

  • Appropriate accounting for differing study designs

  • Impact from differing project sample sizes

The selection of the most appropriate method should be based on a critical evaluation of the specific studies being combined, with careful consideration of how differences in design might influence outcomes .

What are the critical factors to consider when designing experiments to express AGAP010478 in heterologous systems?

When designing experiments to express AGAP010478 in heterologous systems, researchers should consider several critical factors that can significantly impact expression success:

  • Vector Design Considerations:

    • Promoter selection based on expression needs (constitutive vs. inducible)

    • Codon optimization for the host organism

    • Inclusion of appropriate fusion tags for detection and purification

    • Signal sequence inclusion for targeted localization

  • Host Selection Factors:

    • E. coli strains specialized for difficult proteins (e.g., BL21(DE3) derivatives)

    • Alternative hosts for complex proteins (yeast, insect cells, mammalian cells)

    • Host compatibility with the protein's post-translational modification requirements

  • Growth and Induction Parameters:

    • Temperature optimization (standard vs. low-temperature expression)

    • Induction concentration and timing

    • Media composition and supplementation

    • Scale considerations (flask culture vs. bioreactor)

  • Experimental Controls:

    • Empty vector control

    • Known expressible protein positive control

    • Non-induced culture control

The research should be designed as a systematic optimization process rather than a single-condition experiment, with careful documentation of all parameters to facilitate troubleshooting and reproducibility .

How should researchers design cross-resistance studies involving AGAP010478 in Anopheles gambiae?

Designing effective cross-resistance studies involving AGAP010478 in Anopheles gambiae requires a comprehensive experimental approach that addresses multiple levels of analysis:

  • Population Selection:

    • Include both resistant and susceptible mosquito populations

    • Sample from multiple geographical locations to capture genetic diversity

    • Consider both laboratory-selected and field-collected resistant populations

  • Resistance Profiling:

    • Conduct bioassays against multiple insecticide classes

    • Determine LC50 and LC90 values for each insecticide

    • Establish resistance ratios compared to susceptible reference strains

  • Gene Expression Analysis:

    • Utilize whole-genome microarrays or RNA-Seq to identify differentially expressed genes

    • Perform qRT-PCR validation of AGAP010478 expression levels

    • Compare expression patterns across different resistant phenotypes

  • Functional Validation:

    • Express recombinant AGAP010478 and test its ability to metabolize different insecticides

    • Conduct in vitro metabolism assays with appropriate controls

    • Use gene knockout/knockdown approaches to confirm role in resistance

  • Data Analysis Framework:

    • Employ statistical methods that account for geographical and genetic variation

    • Use post-hoc pairwise comparisons to identify significant differences

    • Calculate fold-changes in gene expression with appropriate statistical tests

This multi-faceted approach can help establish whether AGAP010478 contributes to cross-resistance mechanisms similar to those observed with other proteins such as CYP6M2 .

What methodological approaches are most effective for studying AGAP010478 expression in different tissue types of Anopheles gambiae?

Studying AGAP010478 expression across different tissue types in Anopheles gambiae requires specialized methodological approaches to ensure accurate tissue-specific profiling:

  • Tissue Dissection and Preservation:

    • Develop standardized protocols for micro-dissection of mosquito tissues

    • Flash-freeze tissues immediately in liquid nitrogen

    • Consider using RNAlater for field samples to preserve RNA integrity

  • RNA Extraction Optimization:

    • Select extraction methods appropriate for small tissue samples

    • Include carrier RNA for low-yield tissues

    • Implement rigorous quality control (QC) measures for RNA integrity

  • Expression Analysis Techniques:

    • Quantitative RT-PCR:

      • Design primers specific to AGAP010478

      • Validate multiple reference genes for each tissue type

      • Use technical triplicates and biological replicates (minimum n=3)

    • RNA-Seq Approach:

      • Consider low-input RNA-Seq protocols for limited tissue samples

      • Implement appropriate normalization methods

      • Use depth sufficient for detecting low-abundance transcripts

  • Protein Localization:

    • Develop AGAP010478-specific antibodies for immunohistochemistry

    • Consider fluorescent protein tagging in transgenic mosquitoes

    • Use confocal microscopy for high-resolution tissue localization

  • Data Representation:

    • Present expression data in standardized formats using data tables

    • Include fold-changes relative to whole-body expression

    • Report statistical significance with appropriate tests

This comprehensive approach ensures reliable detection and quantification of AGAP010478 across different mosquito tissues, providing insights into its functional role and potential tissue-specific activities .

How can researchers effectively design meta-analyses to integrate findings on AGAP010478 from diverse studies?

Designing effective meta-analyses to integrate findings on AGAP010478 from diverse studies requires a systematic methodological framework:

  • Research Question Formulation:

    • Clearly define specific aspects of AGAP010478 to be investigated

    • Develop explicit inclusion/exclusion criteria for studies

    • Register the meta-analysis protocol in appropriate databases

  • Literature Search Strategy:

    • Utilize multiple databases (PubMed, Web of Science, Scopus)

    • Develop comprehensive search terms including gene identifiers and synonyms

    • Include unpublished studies and conference proceedings to minimize publication bias

  • Data Extraction Framework:

    • Create standardized forms for extracting methodological details

    • Record sample sizes, statistical tests, and effect sizes

    • Document mosquito species, molecular forms, and resistance status

  • Statistical Analysis Approach:

    • Select appropriate meta-analytic models (fixed vs. random effects)

    • Account for study heterogeneity using I² statistics

    • Consider subgroup analyses for different experimental conditions

  • Addressing Study Heterogeneity:

    • Analyze pooled data using prospective meta-analytic techniques

    • Consider weighting studies based on quality assessments

    • Implement sensitivity analyses to test robustness of findings

  • Reporting Standards:

    • Follow PRISMA guidelines for reporting meta-analyses

    • Clearly document methodological decisions and limitations

    • Provide forest plots and other visual representations of findings

What are common challenges in expressing AGAP010478 in E. coli, and how can they be addressed?

Expression of recombinant Anopheles proteins in E. coli often presents several challenges. Based on recombinant protein research, here are common issues with AGAP010478 expression and their solutions:

ChallengePossible CausesSolutions
Low expression levelsCodon bias, promoter strength, plasmid copy numberOptimize codon usage, balance promoter strength and copy number, use specialized expression strains
Protein insolubilityImproper folding, hydrophobic regions, inclusion body formationLower induction temperature (16-25°C), co-express chaperones, use solubility tags (SUMO, MBP, TRX)
Protein toxicityInterference with host metabolism, membrane disruptionUse tightly regulated inducible systems, reduce expression temperature, employ specialized host strains
Protein degradationProtease activity, instabilityAdd protease inhibitors, use protease-deficient strains, optimize buffer conditions
Poor purification yieldInaccessible tags, aggregationTest multiple tag positions, optimize lysis conditions, consider on-column refolding

Consider using the innovative vesicle-nucleating peptide tag system, which has shown success with challenging proteins by compartmentalizing them within membrane-bound vesicles. This system can significantly increase yields of otherwise difficult-to-express proteins and simplifies downstream processing .

How can researchers optimize study design when investigating AGAP010478's role in insecticide resistance across different mosquito populations?

Optimizing study design for investigating AGAP010478's role in insecticide resistance requires careful consideration of multiple factors to ensure robust and comparable results across different mosquito populations:

  • Standardized Resistance Testing:

    • Use WHO tube bioassays or CDC bottle assays with standardized concentrations

    • Include multiple insecticide classes to detect cross-resistance

    • Establish clear resistance classification criteria (mortality percentages)

  • Population Sampling Strategy:

    • Implement adaptive spatial sampling designs for field collections

    • Stratify sampling across different ecological zones

    • Document precise collection locations with GPS coordinates

    • Sample across seasons to account for temporal variation

  • Genetic Background Characterization:

    • Determine molecular forms (M vs. S) of A. gambiae populations

    • Screen for known resistance mutations (kdr, ace-1)

    • Consider whole-genome sequencing for population structure analysis

  • Expression Analysis Controls:

    • Use multiple reference genes validated for stability across populations

    • Include susceptible laboratory strains as baseline controls

    • Process all samples using identical protocols to minimize technical variation

  • Data Analysis Framework:

    • Employ statistical models that account for spatial autocorrelation

    • Use Poisson generalized linear mixed models for count data

    • Calculate fold-changes with appropriate confidence intervals

    • Report FDR-adjusted p-values for multiple comparisons

This comprehensive approach minimizes variation due to methodology and maximizes the ability to detect true biological differences in AGAP010478's role across diverse mosquito populations .

What quality control measures are essential when working with recombinant AGAP010478?

Ensuring high-quality recombinant AGAP010478 requires implementing rigorous quality control measures throughout the production and purification process:

  • Expression Verification:

    • SDS-PAGE analysis with Coomassie staining

    • Western blot using tag-specific or protein-specific antibodies

    • Mass spectrometry confirmation of protein identity

  • Purity Assessment:

    • Densitometric analysis of SDS-PAGE gels (aim for >90% purity)

    • Size exclusion chromatography to detect aggregates

    • Endotoxin testing for proteins intended for functional studies

  • Structural Integrity Verification:

    • Circular dichroism to assess secondary structure

    • Thermal shift assays to evaluate stability

    • Dynamic light scattering to detect aggregation

  • Functional Validation:

    • Activity assays specific to predicted function

    • Binding studies with predicted interaction partners

    • Comparison to positive control proteins when available

  • Storage Stability Assessment:

    • Test multiple buffer conditions for optimal stability

    • Evaluate freeze-thaw stability

    • Monitor activity retention over time

  • Documentation Requirements:

    • Detailed production records including expression conditions

    • Complete purification protocols with all buffer compositions

    • Comprehensive QC results with acceptance criteria

These quality control measures should be implemented systematically and documented thoroughly to ensure reproducible results in downstream applications .

How is CRISPR-Cas9 technology being applied to study AGAP010478 function in Anopheles gambiae?

CRISPR-Cas9 technology has revolutionized functional genomics approaches for studying mosquito genes like AGAP010478. Current applications include:

  • Gene Knockout Studies:

    • Generation of AGAP010478 null mutants to assess phenotypic effects

    • Creation of mosquito lines with fluorescent markers replacing the gene

    • Assessment of fitness costs in laboratory and semi-field conditions

  • Precise Gene Editing:

    • Introduction of specific mutations to study structure-function relationships

    • Creation of variants mimicking naturally occurring polymorphisms

    • Insertion of epitope tags for protein localization studies

  • Conditional Expression Systems:

    • Development of tissue-specific AGAP010478 knockouts

    • Creation of temperature-sensitive or chemically-inducible expression systems

    • Implementation of Gal4/UAS systems for controlled expression

  • High-throughput Phenotyping:

    • Automated tracking of mosquito behavior in AGAP010478 mutants

    • Analysis of insecticide resistance profiles in modified strains

    • Assessment of vector competence and transmission potential

  • Methodological Considerations:

    • Optimization of guide RNA design for mosquito genome editing

    • Development of improved delivery methods for CRISPR components

    • Implementation of homology-directed repair for precise modifications

This technology provides unprecedented opportunities to directly assess AGAP010478's function in vivo, potentially revealing new targets for vector control strategies .

What are the implications of molecular form differences in Anopheles gambiae for AGAP010478 research?

Understanding the implications of molecular form differences in Anopheles gambiae is crucial for accurate interpretation of AGAP010478 research:

  • Genetic Differentiation Between Forms:

    • The M and S molecular forms of A. gambiae (now recognized as separate species: A. coluzzii and A. gambiae s.s.) show significant genetic differentiation

    • Studies have demonstrated different insemination rates between forms (15% in M form vs. 6% in S form)

    • These genetic differences may impact AGAP010478 expression and function

  • Ecological Niche Differences:

    • M form predominates in permanent breeding sites and urbanized areas

    • S form is more common in temporary rain-dependent breeding sites

    • These ecological differences may lead to different selective pressures on AGAP010478

  • Mating Behavior Variations:

    • Research has shown that indoor mating may be an alternative mating strategy of the M molecular form

    • Cross-mating between forms occurs at higher rates indoors than outdoors

    • These behavioral differences may correlate with protein expression patterns

  • Research Design Implications:

    • All AGAP010478 studies should clearly identify and report the molecular form used

    • Comparisons between studies should account for form differences

    • Ideally, research should include both forms to capture the full spectrum of variation

  • Vector Control Relevance:

    • Differential insecticide resistance mechanisms may exist between forms

    • AGAP010478's role in resistance might vary between A. coluzzii and A. gambiae s.s.

    • Form-specific control strategies may be necessary for effective intervention

These considerations highlight the importance of molecular form identification and differentiation in all AGAP010478 research to ensure accurate interpretation of results and effective application to vector control strategies .

How might proteomics approaches enhance our understanding of AGAP010478 function?

Advanced proteomics approaches offer powerful tools to elucidate AGAP010478 function beyond traditional genetic and biochemical methods:

  • Interaction Network Mapping:

    • Proximity-dependent biotin labeling (BioID or APEX) to identify protein interaction partners

    • Co-immunoprecipitation coupled with mass spectrometry

    • Yeast two-hybrid screening validated by in vivo methods

  • Post-translational Modification Analysis:

    • Phosphoproteomics to identify regulatory phosphorylation sites

    • Glycosylation analysis to assess potential secretory pathways

    • Ubiquitination profiling to investigate protein turnover mechanisms

  • Subcellular Localization Studies:

    • Subcellular fractionation coupled with proteomics

    • Spatial proteomics using LOPIT (localization of organelle proteins by isotope tagging)

    • Temporal analysis of protein localization under different conditions

  • Comparative Proteomics:

    • Quantitative comparison between resistant and susceptible mosquito strains

    • Analysis of proteome changes following insecticide exposure

    • Cross-species comparisons of orthologous proteins

  • Structural Proteomics:

    • Hydrogen-deuterium exchange mass spectrometry to map structural features

    • Limited proteolysis coupled with mass spectrometry to identify domains

    • Cross-linking mass spectrometry to determine protein topology

These approaches provide a multi-dimensional view of AGAP010478 function by revealing its interactions, modifications, localization, and structural features in the context of the cell or organism, potentially uncovering novel roles in insecticide resistance or other physiological processes .

What novel expression systems show promise for difficult-to-express mosquito proteins like AGAP010478?

Several innovative expression systems are emerging as promising alternatives for difficult-to-express mosquito proteins like AGAP010478:

  • Cell-Free Expression Systems:

    • Wheat germ extract-based systems for eukaryotic proteins

    • E. coli-based cell-free systems with supplements for membrane proteins

    • Advantages include rapid production, absence of cell viability concerns, and direct incorporation of labeled amino acids

  • Vesicle-Nucleating Peptide Tag System:

    • Novel approach using short peptide tags that export recombinant proteins in membrane-bound vesicles

    • Creates micro-environments facilitating production of challenging proteins

    • Significantly increases yields of toxic, insoluble, or disulfide-bond containing proteins

    • Allows for simplified downstream processing and long-term active protein storage

  • Specialized Insect Cell Lines:

    • Mosquito-derived cell lines for authentic post-translational modifications

    • Drosophila S2 cells with inducible expression systems

    • Sf9 or High Five cells with optimized vectors for high-level expression

  • Transient Plant Expression Systems:

    • Nicotiana benthamiana-based systems using viral vectors

    • Rapid production (5-7 days) with glycosylation capabilities

    • Scalable and cost-effective for research purposes

  • Methylotrophic Yeast Systems:

    • Pichia pastoris (Komagataella phaffii) with strong inducible promoters

    • Capable of high-density fermentation and proper protein folding

    • Performs eukaryotic post-translational modifications

Each system offers distinct advantages depending on the specific challenges presented by AGAP010478, and researchers should consider protein characteristics and downstream applications when selecting the most appropriate expression platform .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.